|Bid||17.67 x 2200|
|Ask||0.00 x 1100|
|Day's Range||17.69 - 17.73|
|52 Week Range||12.10 - 17.89|
|Beta (3Y Monthly)||-0.31|
|PE Ratio (TTM)||54.52|
|Earnings Date||May 8, 2019 - May 13, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||17.63|
NEW YORK , Feb. 14, 2019 /PRNewswire/ -- Civitas Solutions, Inc. (CIVI) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Civitas ...
NEW YORK, Feb. 10, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Fidelity Southern.
On a per-share basis, the Boston-based company said it had profit of 18 cents. Earnings, adjusted for one-time gains and costs, were 50 cents per share. The provider of group homes and home-based care ...
BALA CYNWYD, PA / ACCESSWIRE / January 31, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Civitas Solutions, Inc. ("Civitas" or "the Company") (CIVI) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Centerbridge Partners L.P. ("Centerbridge"). Under the terms of the transaction, Civitas shareholders will receive only $17.75 in cash for each share of Civitas stock they own. The investigation concerns whether the Board of Civitas breached their fiduciary duties to shareholders and whether Centerbridge is underpaying for the Company.
NEW YORK, NY / ACCESSWIRE / January 29, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New ...
Civitas Solutions, Inc. (“Civitas”) announced today that it has filed a preliminary proxy statement with the Securities and Exchange Commission for a special meeting of stockholders to consider the previously announced definitive merger agreement between Civitas and funds advised by Centerbridge Partners, L.P. (“Centerbridge”). In light of the proposed merger, Civitas will not hold its 2019 annual meeting of stockholders on March 8, 2019. The date of the special meeting of stockholders will be specified in a definitive proxy statement to be mailed to Civitas’ stockholders.
KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (email@example.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-civi/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
NEW YORK , Jan. 2, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...
NEW YORK, Jan. 02, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
NEW ORLEANS , Dec. 20, 2018 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale ...
Moody's Investors Service ("Moody's") today placed the ratings of National MENTOR Holdings, Inc. ("National MENTOR"), including the B1 Corporate Family Rating (CFR), under review for downgrade. Civitas Solutions, Inc., is the indirect parent company of National MENTOR and the publicly listed entity.
NEW YORK, Dec. 19, 2018 -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Civitas Solutions, Inc. (NYSE: CIVI) on behalf of.
NEW YORK , Dec. 19, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Civitas Solutions, Inc. (NYSE: CIVI) and its board of directors for breach of fiduciary duty concerning ...
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples Read More...
SHAREHOLDER ALERT: WeissLaw LLP Investigates Civitas Solutions Inc. NEW YORK, NY / ACCESSWIRE / December 19, 2018 / WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations ...
SAN DIEGO , Dec. 18, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Civitas Solutions, Inc. (NYSE: CIVI) ("Civitas") ...
Under the terms of the deal, Centerbridge will acquire all outstanding shares of the Boston-based health-service provider’s common stock for $17.75 a share.
Do you own shares of Civitas Solutions, Inc. (NYSE: CIVI)? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Civitas Solutions, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by funds advised by Centerbridge Partners, L.P. (“Centerbridge”) in a transaction valued at approximately $1.4 billion. If you own common stock of Civitas and purchased any shares before December 18, 2018, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra toll-free at (888) 969-4242, by e-mail at firstname.lastname@example.org, or at https://www.rigrodskylong.com/offices-contact.
NEW YORK, Dec. 18, 2018 -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Civitas Solutions, Inc. (“Civitas”.
Centerbridge Partners L.P. has inked a deal to buy Civitas Solutions Inc. for $1.4 billion, the company said late Tuesday. Civitas stock was up 5% after hours. Civitas said that Centerbridge would pay $17.75 a share in cash. Civitas stock has fallen 8.5% this year, as the S&P 500 index fell 4.8%.
Civitas Solutions, Inc. (“Civitas” or the “Company”) (CIVI) today announced that it has entered into a definitive merger agreement to be acquired by funds advised by Centerbridge Partners, L.P. (“Centerbridge”). Under the terms of the agreement, Centerbridge will acquire all outstanding shares of Civitas common stock for $17.75 in cash per share of Civitas common stock, resulting in an enterprise value of approximately $1.4 billion. “We are excited about this transaction, which follows a thorough review of alternatives by our Board of Directors,” said Bruce Nardella, President and Chief Executive Officer of Civitas.
CORAL GABLES, FL / ACCESSWIRE / December 14, 2018 / The noticeable stock price volatility has been seen during recent weeks of trading. Healthcare stocks and biotechnology companies have generally been a safe haven for market participants over the years. Keeping this in mind, here are some healthcare stocks to watch this month: Premier Health Group, Inc. (OTC:PHGRF) (CSE:PHGI), Generex Biotechnology Corporation (GNBT), Civitas Solutions, Inc. (CIVI), and Innovate Biopharmaceuticals, Inc. (INNT).